The mitochondrial tricarboxylic acid cycle enzyme malate dehydrogenase was purified from Saccharomyces cerevisiae, and an antibody to the purified enzyme was obtained in rabbits. Immunoscreening of a yeast genomic DNA library cloned into a lambda gtll expression vector with anti-malate dehydrogenase immuno. globulin G resulted in identification of a lambda recombinant encoding an immunoreactive ,l-galactosidase fusion protein. The yeast DNA portion of the coding region for the fusion protein translates into an amino acid sequence which is very similar to carboxy-terminal sequences of malate dehydrogenases from other organisms.
The mitochondrial isozyme of malate dehydrogenase has key functions in the tricarboxylic acid (TCA) cycle and in the malate-aspartate shuttle of reducing equivalents across the organelle membrane. Due to the unfavorable equilibrium for oxaloacetate production, it has been postulated that a physical association between malate dehydrogenase and citrate synthase, the next enzyme in the TCA cycle, must exist to allow direct exchange of this molecule (40) . In vitro, purified malate dehydrogenase can form a stable physical complex with citrate synthase (9) or with aspartate aminotransferase (2) , an association which presumably would enhance shuttle cycle function. An additional level of regulation, or perhaps correlative to formation of alternative enzyme complexes, is the allosteric interaction of malate dehydrogenase with citrate (28) .
In addition to extensive kinetic analyses of the enzyme, the structure of mitochondrial malate dehydrogenase is well defined. The enzyrme from most organisms is a dimer composed of identical subunits with approximate molecular weights of 34,000 (1) . The amino acid sequence of the porcine enzyme has been determined (4) , and the sequence has been correlated with the crystallographic structure of the enzyme (32) . Particularly instructive are comparisons of this structure with that determined for the porcine cytoplasmic enzymne, which is also a dimer with a subunit molecular weight of 36,000 and which also functions in the malateaspartate shuttle. The primary structures of the compartmentalized isozymes show a low degree of similarity (approximately 20% [4] ), yet the main chain folding of the two proteins is remarkably similar (32; J. J. Birktoft, R. A. Bradshaw, and L. J. Banaszak, submitted for publication). Structural features associated with catalysis, substrate and cofactor binding, and subunit interactions are similar. For example, the catalytic mechanisms of both enzymes involve homologous histidine and aspartate residues (3). The overall low level of sequence relatedness presumably reflects other differential functions for the compartmentalized isozymes. This idea is supported by comparison of the primary sequences for eucaryotic mitochondrial malate dehydro-* Corresponding author.
genases with that for malate dehydrogenase from Escherichia coli (L. McAlister-Henn, M. Blaber, R. A. Bradshaw, and S. J. Nisco, submitted for publication). The amino acid sequences are 59% identical, indicative of dramatic evolutionary conservation of the TCA cycle enzyme.
We wish to develop a eucaryotic molecular genetic system that can be exploited for in vivo tests of correlates between structure and function of mitochondrial malate dehydrogenase and of the role of this enzyme in regulation of the TCA cycle. Since yeast genes can be manipulated in vitro and reintroduced into their proper chromosomal location through transformation (17) , and since Saccharomyces cerevisiae is particularly amenable to study of mutations affecting mitochondrial functions (recently reviewed by Tzagoloff and Myers [42] ), we have isolated the gene for mitochondrial malate dehydrogenase from S. cerevisiae. Details of the isolation of this gene through immunoscreens of a yeast genomic library in lambda gtll are presented in this report. Initial studies of expression of the gene are also described.
MATERIALS AND METHODS
Strains and growth conditions. E. coli Y1090 {AlacUJ69 proA+ Alon araD139 strA supF [trpC222::TnJO](pMC9); 43} was used for lambda gtll transfection, immunoscreening, and preparation of lysogens. This strain was grown in LB medium containing 0.2% maltose and 50 p,g of ampicillin per ml. E. coli HB101 was grown on M-9 minimal medium (27) containing 0.2% glucose and 50 ,ug of ampicillin per ml for amplification of plasmid DNAs. Strain JM105, used for propagation of M13 phage derivatives, was maintained on M-9 agar plates and grown on 2 x YT medium (26) for transformations and plating.
The haploid yeast strain Sg7 (a leu2 his3-AJ trpl gcrl-J), constructed through a cross of S. cerevisiae strains S173-29A (a leu2-3 leu2-112 his3-AJ adel-101 trpl-289; 5) and DFY67 (a leu2 lysi trpl gcrl-J; 8) , was used for isolation of mitochondrial malate dehydrogenase. Yeast transformations were conducted by using the lithium acetate protocol (18) with strains S173-6B (a leu2-3 leu2-112 his3-Al ura3-52 trpl-289; 5) and S173-6B/SB, a diploid constructed by cross-ing S173-6B with S173-SB (ot leu2-3 leu2-112 adel-101 ura3-52 trpl-289; 24 Isolation of yeast mitochondrial malate dehydrogenase. Yeast strain Sg7 was cultivated in YP medium containing 2% glycerol plus 2% lactate as carbon source. Cells were harvested at mid-log phase (A6N, 1.5) by centrifugation at 3,000
x g. The cell pellets were washed with distilled water and suspended to a concentration of 1 g of cells per 5 ml of a buffer containing 50 mM NaPO4 (pH 7.4), 5 mM EDTA, 5 mM P-mercaptoethanol, and 50% glycerol. The cell suspension was frozen by dripping into liquid nitrogen and stored at -700C.
For enzyme isolation, 90 g of frozen cells was thawed in 100 ml of buffer A (10 mM NaPO4 [pH 7.4 ], 1 mM EDTA, 1 mM P-mercaptoethanol) plus 10 mM phenylmethylsulfonyl fluoride and broken with glass beads, using a Bead Beater (Biospec Products, Bartlesville, Okla.). During breaking, the cells were maintained at 4 to 7°C in an ice-chilled chamber by alternating eight cycles of 1-min rotor bursts with 1-min intervals. The lysate was cleared by centrifugation at 10,000 x g for 10 min. The glass bead break was repeated, using the lysate pellet, and the supernatants from both breaks were combined. Nucleic acids were removed from the crude supernatant by precipitation with 0.25% protamine sulfate and centrifugation. The resulting supernatant was loaded slowly onto a CL-6B Blue Sepharose column (70-ml column bed; Pharmacia, Inc., Piscataway, N.J.) previously equilibrated with buffer A. The column was washed with 600 ml of buffer A, and bound proteins were eluted with a 500-ml 0.0 to 2.0 M KCl gradient. Malate dehydrogenase, assayed in 10-ml fractions collected during the gradient elution, was resolved into two distinct forms. The fractions containing the mitochondrial isozyme, initially identified on the basis of elution profiles reported by others (16; E. R. Dickman, Ph.D. thesis, Albert Einstein College of Medicine, New York, N.Y., 1976) and later by size and cellular localization of the purified protein as described in the text, were pooled and dialyzed for 24 h at 4°C with three changes of 3 liters each of buffer A. The dialysate was loaded onto a DEAE-cellulose column preequilibrated with buffer A. Proteins were eluted with a 0.0 to 0.5 M KCl gradient, and fractions containing malate dehydrogenase activity were pooled and precipitated with 60% ammonium sulfate. The precipitate was suspended in 3 ml of buffer B (50 mM NaPO4, pH 7.4), dialyzed, and loaded onto a Sephacryl S-200 gel filtration column (1.5 by 80 cm; Pharmacia) equilibrated with the same buffer. Following elution with buffer B, fractions containing malate dehydrogenase activity were pooled and loaded onto a 2-ml CL-6B/Blue Sepharose column preequilibrated with buffer B. Malate dehydrogenase was eluted with buffer B containing 12 mM NADH, dialyzed, and stored in buffer B containing 50% glycerol. These steps resulted in an overall increase in specific activity of malate dehydrogenase from 3.63 U/mg of protein in the crude extract to 308.7 U/mg in the purified sample. Protein concentrations were measured by the method of Lowry et al. (20) (37) . The IgG used to screen the library was a 1:100 dilution of the anti-malate dehydrogenase IgG which had been preincubated with nitrocellulose filters lifted from mock-infected plaques, a procedure which substantially reduces IgG interactions with bacterial antigens.
Lysogens were prepared by infecting E. coli Y1090 cells and isolating colonies from the center of phage plaques which were capable of growth at 30°C but not at 42°C. The latter temperature inactivates the temperature-sensitive c1857 repressor encoded by the phage leading to prophage induction and lysis in this strain (43) . To examine fusion proteins, lysogens were grown in 15-ml cultures of LB containing 10 mM MgCl and 0.2% maltose. When the cultures reached A6N of 0.5, isopropyl-P-D-thiogalactopyranoside was added to a concentration of 10 mM to induce the lacZ promoter and the cultures were shifted to 42°C for 20 min and then to 37°C for 2 h. A 300-,ui portion of chloroform to ensure complete lysis and 300 ,ul of a 10-mg/ml concentration of phenylmethylsulfonyl fluoride were added, and the incubations were continued for 30 min at 37°C. and heated in a boiling-water bath for 3 min prior to electrophoresis.
Total cellular protein samples from yeast cells were obtained by vortexing cell pellets with glass beads as previously described (25) . The pellets were broken in buffer A (described above) with 10 mM phenylmethylsulfonyl fluo-ride, and the lysates were cleared by centrifuging for 10 min in an Eppendorf centrifuge. The supernatants were used directly for enzyme assays or diluted with an equal volume of SDS sample buffer for electrophoresis.
Nucleic acid hybridizations. Lambda DNA was isolated from 250-ml cultures of lysogens and purified by cesium chloride gradient centrifugation as described by Maniatis et al. (21) . Plasmid DNA was prepared from chloramphenicoltreated bacterial cultures and purified by hydroxyapatite column chromatography (36) . Yeast genomic DNA was isolated as described previously (23) . Hybridization probes labeled with [a-32P]dATP were prepared by the random primer method (12) with DNA fragments isolated from 0.8% low-melt agarose gels.
To screen the Naysmyth-Tatchell yeast genomic recombinant plasmid library (29), E. coli HB101 was transformed and plated at a density of 600 transformant colonies per plate on 12 large (20-cm) petri plates containing LB agar plus 50 ,ug of ampicillin per ml. The colonies were transferred to Whatman 540 filter papers for lysis and hybridization (13) . Hybridization with 32P-labeled DNA fragments was conducted at 65°C, using 3x SSC (lx SSC = 0.15 M NaCl plus 15 mM sodium citrate, pH 7.0) containing 0.02% each bovine serum albumin, Ficoll, and polyvinylpyrrolidone plus 10 Rg of depurinated salmon sperm DNA per ml. Positive transformants obtained in the initial screen were streaked onto LB-ampicillin plates to obtain single colonies for secondary hybridization.
For Southern hybridizations, DNA restriction fragments were electrophoresed on 0.8% agarose gels, transferred to nitrocellulose as described by Southern (39) , and hybridized with 32P-labeled DNA probes as described above for colony hybridizations.
For Northern (RNA) blot hybridizations, total cellular RNA was prepared from yeast cell pellets as described previously (22) . RNA samples of 15 ,g were electrophoresed on 1% agarose-formaldehyde gels and transferred to nitrocellulose filters. The filters were hybridized with 32P-labeled DNA fragments for 24 h at 42°C in 5 x SSC containing 50% formamide, 10 ,ug of salmon sperm DNA per ml, and 0.2% each bovine serum albumin, Ficoll, and polyvinylpyrrolidone and then washed with three changes of 5x SSC at 42°C for 30 min prior to autoradiography.
Nucleotide sequence analysis. The dideoxy primer extension protocol (35) was used for nucleotide sequence analysis of DNA fragments subcloned into single-stranded M13 plasmids (26) . The primers were 17-mer sequencing oligonucleotides obtained from New England BioLabs, Inc., Beverly, Mass.
Cell fractionation. Mitochondria were prepared as described by Daum et for mitochondrial functions for growth of this strain, the specific activity of malate dehydrogenase is two-to threefold higher in crude extracts prepared from Sg7 than in extracts from other yeast strains which lack the gcr mutation. Approximately 5 mg of the enzyme was purified from 90 g (wet weight) of cells harvested from cultures grown to early log phase on YP medium with 2% glycerol plus 2% lactate as carbon sources. Details of the purification protocol are described in Materials and Methods. The mitochondrial and cytoplasmic isozymes were resolved in an initial chromatography step, using a 0.0 to 2.0 M KCI gradient to obtain differential elution from a CL-6B Blue Sepharose column. In subsequent purification steps, malate dehydrogenase activity correlated with the presence of a single mitochondrial isozyme. The profile of proteins at each stage of purification is illustrated in Fig. 1 Antiserum against yeast mitochondrial malate dehydrogenase was prepared by injection of rabbits with the native form of the purified enzyme. The IgG fraction obtained from the rabbit serum as described in Materials and Methods reacts well against immunoblots of the purified enzyme and with a polypeptide with the appropriate molecular weight in total yeast cellular extracts (Fig. 2A) . The antiserum strongly inhibits the activity of the purified mitochondrial enzyme, but does not affect the activity of a partially purified cytoplasmic isozyme or react with immunoblots of the latter (data not shown).
Isolation of the mitochondrial malate dehydrogenase gene. The anti-malate dehydrogenase IgG was used to screen the lambda gtll yeast genomic DNA library constructed by Snyder and Davis (37), using protocols described in Materials and Methods. This library contains 2-to 4-kilobase-pair (kbp) fragments of randomly sheared yeast chromosomal DNA cloned into the EcoRI restriction site near the 3' end of the lacZ gene of E. coli. Yeast genes in the proper orientation and reading frame may be expressed as fusion proteins under control of the lacZ promoter. One million recombinant phage were screened and eight positive phage were identified with the anti-malate dehydrogenase IgG. The eight phage were purified through two or three cycles of plating to obtain single plaques. Only three of the original eight phage maintained strong immunoreactivity after replating, and plaques of one of these phage, lambda M8, were particularly reactive (Fig. 2B ).
Lysogens were prepared by infecting E. coli Y1090 with the three purified recombinant phage recovered from the immunoscreen. Synthesis of putative P-galactosidase fusion proteins in the lysogens was induced by addition of isopropyl-o3D-thiogalactopyranoside, and lysis was induced by shifting lysogen cultures to 42°C. Soluble proteins were recovered by ammonium sulfate precipitation as described in Materials and Methods and examined by SDS-polyacrylamide gel electrophoresis and immunoblotting. Only one of the lysogen extracts, that from cells infected with phage lambda M8, was found to contain a protein larger than 0-galactosidase which reacted with anti-malate dehydrogenase IgG (Fig. 3) . Extracts from the other two lysogens contained reduced levels of P-galactosidase, but no immunoreactive proteins were detected (data not shown).
Since fusion proteins may exhibit differential stabilities, purified lambda DNA was obtained from the three Y1090 lysogens to examine relatedness through cross-hybridization. Yeast DNA fragments of 2.5 kbp from lambda M8 and 3.0 and 3.5 kbp from the other lambda DNAs were recovered by EcoRI restriction digestion. These fragments failed to cross-hybridize in dot blot or Southern blot analyses and therefore appear to be nonoverlapping fragments of yeast genomic DNA.
The yeast DNA EcoRI fragment from lambda M8 was subcloned into M13mpl8 for DNA sequence analysis, since the coding region for the immunoreactive yeast protein should abut the EcoRI site in the P-galactosidase gene.
Nucleotide sequence information was obtained from both ends of the EcoRI fragment. The sequence derived from the orientation shown in Fig. 4 encodes an open reading frame which can be translated into 51 amino acid residues between the EcoRI boundary and a UAG stop codon. This partial protein sequence is similar to aligned amino acid sequences from the carboxy termini of porcine mitochondrial and E. coli malate dehydrogenases (Fig. 5) inserts from plasmids (designated YEpMl, YEpM1O, and YEpM12) isolated from these transformants contain nonidentical but overlapping fragments of yeast genomic DNA.
.. F F A S P V T L G P D G I E K I H P I G E
Yeast strain S173-6B was transformed with each of the YEp13 recombinant plasmids, and transformants were isolated as Leu+ colonies. Protein extracts were prepared from the transformants and examined for expression of malate dehydrogenase by enzyme assays and immunoblotting. The total specific activity of malate dehydrogenase measured for extracts from cells transformed with YEpM1O was five-to sevenfold higher than levels measured for cells transformed with YEpM1, YEpM12, or a YEp13 control plasmid. These differences in specific activity correlated well with differences in levels of immunoreactive mitochondrial malate dehydrogenase in the same extracts as shown in Fig. 6A .
Since the levels of malate dehydrogenase in cells transformed with YEpM1 or YEpM12 were similar to those in control transformants or nontransformed cells, we assume that the yeast DNA fragments in these recombinant plasmids do not contain the complete gene for malate dehydrogenase. By comparing restriction maps and hybridization patterns, using the EcoRI fragment from lambda M8 as a probe, we determined the approximate location of the coding region for the malate dehydrogenase gene on the yeast DNA fragment in YEpM1O shown in Fig. 4 . To test this localization, the 3.0-kbp SphI fragment from the YEpM1O DNA insert was subcloned into YEp13 for transformation into yeast cells. The total specific activity of malate dehydrogenase in extracts from independent transformants was found to be sixto eightfold above control levels.
To examine the cellular localization of the plasmidencoded malate dehydrogenase, mitochondria were prepared from YEpM1O transformants and from nontransformed S173-6B cells grown to mid-log phase on minimal medium (YNB) containing 2% glycerol plus 2% lactate as carbon sources. The activities of malate dehydrogenase and a mitochondrial marker enzyme, isocitrate dehydrogenase (NAD+), were measured in the mitochondrial and postmitochondrial fractions (Table 1 ). In the nontransformed cells, 13% of the total malate dehydrogenase activity was found to be associated with the mitochondria, whereas in YEpM1O transformants the mitochondrial fraction contained 49% of the total activity. The absolute levels of malate dehydrogenase activity in YEpM1O transformants were more than eightfold higher than those in the mitochondrial fraction but only slightly elevated over levels in the postmitochondrial fraction from nontransformed cells. Judging from the distribution of isocitrate dehydrogenase activity in the subcellular fractions, the mitochondrial fractions are estimated to be 85 to 90% pure. The levels of the mitochondrial enzyme in the different cell fractions were examined by immunoblotting (Fig. 6B ) and estimated by densitometric measurements. The increase in malate dehydrogenase activ- on August 27, 2017 by guest http://jb.asm.org/ Downloaded from ity in YEpM1O transformants was due to an eightfold increase in the level of the isozyme associated with the mitochondria in these cells.
Expression of yeast mitochondrial malate dehydrogenase was also examined in YEpM1O transformants and nontransformed cells grown with either 2% glucose or 2% glycerol plus 2% lactate as carbon sources, conditions which respectively result in repression and derepression of many mitochondrial functions in yeast cells. Cells were harvested from cultures grown in YNB medium with different carbon sources, and the pellets were divided for isolation of total cellular RNA and for preparation of protein extracts as described in Materials and Methods. The protein extracts were assayed for malate dehydrogenase activity and immunoreactivity. Total cellular malate dehydrogenase activity in nontransformed cells was sevenfold higher with growth on glycerol plus lactate as compared with growth on glucose. A similar sixfold differential with these carbon sources was observed for cells transformed with YEpM1O. However, the absolute levels of malate dehydrogenase activity in transformants were approximately fivefold higher than in nontransformed cells with both types of carbon sources, reflecting increased levels of the plasmid-encoded enzyme. The specific derepression of the mitochondrial isozyme, examined by immunoblotting (Fig. 6C) , was approximately sixfold in both transformed and nontransformed cells.
To determine whether the increased levels of the mitochondrial enzyme in glycerol/lactate-grown cells are due to an increase in levels of mRNA, Northern blot analysis was conducted, using total cellular RNA isolated from the YEpM1O transformant and nontransformed cells. The 32P_ labeled SphI fragment from YEpM1O which contains the malate dehydrogenase gene hybridized with a single RNA species of approximately 1.7 kilobases in RNA samples from transformed and control cells (Fig. 7) . The level of the hybridizing transcript was elevated in RNA samples from both the transformant (lane b) and control cells (lane d) grown on glycerol plus lactate as compared with growth on glucose (lanes a and c, respectively). The relative level of the transcript estimated from dot blot titrations was eight-to tenfold higher in transformed cells than in controls under both growth conditions. Disruption of the chromosomal malate dehydrogenase gene. To assess the phenotype of a yeast mutant deficient in expression of mitochondrial malate dehydrogenase, the isolated gene was used to disrupt (34) the chromosomal gene. For this disruption, a 1.1-kbp HindIII fragment containing a selectable yeast URA3 gene was inserted into the HindIII restriction site in the malate dehydrogenase gene on plasmid YIpM1 (Fig. 4) . This insertion interrupted the coding region within sequences encoding the amino terminus of the protein, as determined by partial nucleotide sequencing (data not shown). The SphI fragment containing the URA3 insertion was transformed into haploid and diploid yeast strains. The disruption of the chromosomal gene in Ura+ transformants was confirmed by Southern blot analyses (Fig. 8) .
Insertion of the 1.1-kbp URA3 gene increased the size of a 2.2-kbp EcoRI genomic DNA fragment containing a portion of the malate dehydrogenase gene to approximately 3.3 kbp. This fragment in DNA from haploid and diploid transformants hybridized with 32P-labeled DNA probes from both the malate dehydrogenase (Fig. 8A ) and the URA3 (Fig. 8B from haploid S. cerevisiae ( Fig. 8; data not shown) . We have found no evidence for structurally related sequences in DNA or RNA hybridizations or any evidence for cross-reacting proteins in immunochemical tests. This suggests that the yeast cytoplasmic enzyme is structurally distinct from the mitochondrial isozyme, as is the case for the porcine cellular isozymes which exhibit minimal relatedness at the level of amino acid sequence (4) . It is interesting at this point to note the very different patterns for evolution of the yeast citrate synthase isozymes. The mitochondrial and cytoplasmic enzymes are very similar (75% homologous), whereas they share only 20% homology with citrate synthase from E. coli (33) .
